Latest Channelopathy Stories
A South Jersey man says his eyesight is returning, weeks after doctors at Wills Eye Institute in Philadelphia implanted electrodes behind his left eye. Michael Adler, 49, began losing his sight as a child, The Philadelphia Inquirer reported Tuesday.
Seven applicants receive a total of over $1.7 million BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program.
Using a common cold virus to deliver a corrected gene to cystic fibrosis cells restores normal function to lung tissue, researchers in North Carolina said. The treatment is the most efficient gene therapy for cystic fibrosis to be found in the last 20 years, researchers at the University of North Carolina said Tuesday in a release. The next step is to ensure the safety of the delivery system so it can be administered to cystic fibrosis patients, who suffer from thicker-than-normal mucus that...
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.
LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP).
WASHINGTON, May 21 /PRNewswire-USNewswire/ -- Before your kids are out the schoolroom door and off to the pool or baseball field this summer, take a few preventive steps to help protect their hearts. Prevention may be as simple as making sure children eat nutritious meals, exercise, stay away from cigarettes and have check-ups. Be aware that for some children who have an inherited heart disorder known as Long QT Syndrome, research shows that typical summer activities can trigger sudden...
U.S. pharmaceutical researchers say a new sodium channel blocker is showing promise as a potential treatment for cystic fibrosis. Scientists who developed the drug at Parion Sciences Inc.
Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C.
The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease â€“ the features or disorders associated with it â€“ vary in type and severity among those who are affected. Scientists, physicians and patients all ask why.
WASHINGTON, April 29 /PRNewswire/ -- Vision loss is a high priority area for VA Research.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.